focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Ecolab To Acquire Bioquell For GBP141 Million

Fri, 30th Nov 2018 07:38

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday as investors await a meeting of US and Chinese leaders at the G20 summit.IG futures indicate the FTSE 100 index is to open down 3.25 points at 7,035.70. The blue chip index closed up 34.43 points, or 0.5%, at 7,038.95 Thursday.In early UK corporate news, Babcock International group won a new contract in Canada and Bioquell agreed to be acquired by St Paul, Minnesota-headquartered firm Ecolab. FTSE 250-listed Babcock International said it won its first firefighting contract outside Europe. The contract from the government of Manitoba in Canada is worth around GBP100 million over ten years and will begin in April next year. The engineering services company said it will manage, maintain and operate Manitoba's fleet of seven firefighting fixed-wing Canadair water-bomber amphibious aircraft, supported by three of its own twin commander aircrafts. "This marks our first aviation emergency services contract in Canada, and we are delighted to be trusted to deliver this critical service. We have over 30 years' experience of aerial firefighting, and this new contract positions us well for any future opportunities in the North American market," said Chief Executive Archie Bethel. Biodecontamination products provider Bioquell said it has agreed to be acquired by US water, hygiene and energy technologies provider Ecolab for 590 pence in cash.The deal values Bioquell at around GBP140.5 million and the offer represents a 40% premium to Bioquell's closing share price of 420 pence on Thursday. Bioquell said its board has unanimously recommended Ecolab's offer to shareholders."As part of Ecolab, Bioquell will be able to drive faster strategic growth in both life sciences and healthcare markets leveraging Ecolab's extensive global footprint. The Bioquell Directors believe the strategic fit is extremely strong and that the combination offers employees and customers a highly desirable opportunity to continue Bioquell's successful tradition," said Bioquell Chairman Ian Johnson. Irish drugmaker Shire said it obtained European approval for its human monoclonal antibody Takhzyro intended for treatment of hereditary angioedema. Late Thursday, index provider FTSE Russell said Shire shares will be de-listed in London on January 2 due to its acquisition by Japan's Takeda Pharmaceutical. Later Friday, world leaders are set to open a two-day Group of 20 summit in Argentina, with global trade concerns expected to dominate, while the flare up in Russia-Ukraine tensions and the fallout from the murder of Saudi dissident Jamal Khashoggi are also likely to feature.While there have been some signs that Chinese and US delegations could reach a ceasefire on trade, there are growing worries that President Donald Trump and President Xi Jinping will not be able to make a breakthrough at their highly-anticipated meeting at the summit.Before departing Washington on Thursday, Trump said he was "very close" to reaching a deal with China but added: "I don't know that I want to do it because what we have right now is billions and billions of dollars coming into the US in the form of tariffs or taxes."The pound was flat, quoted at USD1.2778 from USD1.2780 at the London equities close Thursday.The pound remained under pressure after UK Prime Minister Theresa May on Thursday warned of a no-deal Brexit if parliament votes down her deal on December 11.The economic events calendar has Italy inflation and unemployment figures at 0900 GMT and 1000 respectively, and eurozone unemployment and inflation readings at 1000 GMT.In the US on Thursday, Wall Street ended lower, with the Dow Jones Industrial Average down 0.1%, S&P 500 down 0.2% and Nasdaq Composite ending 0.3% lower.Minutes from the Federal Reserve's monetary policy meeting held earlier this month are likely to reinforce expectations for another quarter-point increase in US interest rates next month.The minutes of the Federal Open Market Committee meeting said almost all participants agreed another increase in rates was "likely to be warranted fairly soon".The Fed noted a near-term rate hike would be dependent on incoming information on the labour market and inflation coming in line with or stronger than current expectations.In Asia, the Japanese Nikkei 225 index closed up 0.4%. In China, the Shanghai Composite closed up 0.7%, and the Hang Seng index in Hong Kong is up 0.6%.China's manufacturing activity continued to slow in November amid a prolonged trade war with the US, official data showed Friday.The manufacturing purchasing managers index came in at 50, compared to 50.2 in October, its worst result in more than two years. A figure above 50 indicates growth and one below 50 indicates contraction.The services PMI also slowed to 53.4 this month, down from 53.9 in October, the National Bureau of Statistics said.China's economy is feeling the effects of tariffs imposed earlier this year by the US, which accuses Beijing of unfair trade practices.

More News
30 Nov 2018 07:23

Shire gets EC approval for hereditary angioedema jab

(Sharecast News) - Shire's injectable treatment for hereditary angioedema (HAE) has been cleared for launch in European, having enjoyed early success in the US.

Read more
28 Nov 2018 07:53

Shire's Lanadelumab Help Study Meets Primary And Secondary Endpoints

LONDON (Alliance News) - Shire PLC said Tuesday it has published the full results of its phase III Help study of its hereditary angioedema drug Lanadelumab showing that the study met all of its is

Read more
20 Nov 2018 14:34

EU clears Takeda's Shire acquisition on divestment condition

(Sharecast News) - The European Commission has cleared Takeda Pharmaceutical's £46bn acquisition of Shire, subject to the divestment of a bowel disease drug under development by Shire.

Read more
1 Nov 2018 12:48

TOP NEWS: Shire Revenue Climbs On Strong Performance From Immunology

LONDON (Alliance News) - Shire PLC on Thursday updated its guidance and said its revenue grew in the third quarter of of 2018 as a result of strong Immunology division growth, recent product and a

Read more
1 Nov 2018 12:09

Shire sales remain solid, Takeda deal 'on track'

(Sharecast News) - Shire Pharmaceuticals, the subject of a $62bn takeover by Japan's Takeda, said its focus on rare diseases had offset foreign exchange weakness and boosted third-quarter profits.

Read more
1 Nov 2018 08:48

LONDON MARKET OPEN: Oil Stocks And Strong Pound Weigh On FTSE 100

LONDON (Alliance News) - Stocks in London opened mixed on Thursday, with heavyweight oil majors and a stronger pound hampering the FTSE 100, ahead of the Bank of England's interest rate decion

Read more
31 Oct 2018 06:11

Takeda's raises full-year outlook after Q2 profit rise

TOKYO, Oct 31 (Reuters) - Takeda Pharmaceutical Co Ltd on Wednesday raised its annual operating profit outlook to 268.9 billion yen. That compares with an earlier company estimate of yen an

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 10:51

WINNERS & LOSERS SUMMARY: HSBC Rises After Upbeat Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------HSBC,

Read more
29 Oct 2018 07:35

LONDON MARKET PRE-OPEN: Better-Than-Expected HSBC To Lift FTSE 100

LONDON (Alliance News) - Stocks in London are set to open on firmer ground on Monday, following last week's sell-off, while traders eye Chancellor Philip Hammond's UK government shares in in

Read more
26 Oct 2018 07:52

Takeda Secures JPY1 Trillion Of Financing To Help Shire Deal

LONDON (Alliance News) - Japan's Takeda Pharmaceuticals Inc on Friday said it has secured new financing to help it with its acquisition of FTSE 100 member Shire PLC.The new short-term a

Read more
25 Oct 2018 16:21

Shire hopes to get green light for US Flexbumin manufacture

(Sharecast News) - Shire on Thursday filed a submission to the US food and drug administration to gain approval to manufacture Flexbumin at its new facility in the state of Georgia.

Read more
25 Oct 2018 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 26 October GlencoreQ3 ProductionInternational Consolidated Airlines GroupQ3 Bank 1

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.